Rating History for Atea Pharmaceuticals (AVIR) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/13/2024 | Matthew Harrison | Upgrade | Equalweight (Underweight) |
6.88 (2.00) |
3.37 (5.89) |
74.78% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
